Parametric Portfolio Associates’s Rubius Therapeutics, Inc RUBY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $289K | Buy |
52,432
+70
| +0.1% | +$386 | ﹤0.01% | 3298 |
|
|
2021
Q4 | $507K | Sell |
52,362
-33,347
| -39% | -$323K | ﹤0.01% | 3067 |
|
|
2021
Q3 | $1.53M | Sell |
85,709
-51,470
| -38% | -$920K | ﹤0.01% | 2586 |
|
|
2021
Q2 | $3.35M | Buy |
137,179
+46,511
| +51% | +$1.14M | ﹤0.01% | 2127 |
|
|
2021
Q1 | $2.4M | Buy |
90,668
+42,709
| +89% | +$1.13M | ﹤0.01% | 2666 |
|
|
2020
Q4 | $364K | Buy |
47,959
+8,750
| +22% | +$66.4K | ﹤0.01% | 3521 |
|
|
2020
Q3 | $196K | Sell |
39,209
-7,435
| -16% | -$37.2K | ﹤0.01% | 3662 |
|
|
2020
Q2 | $279K | Buy |
46,644
+33,597
| +258% | +$201K | ﹤0.01% | 3505 |
|
|
2020
Q1 | $58K | Sell |
13,047
-3,338
| -20% | -$14.8K | ﹤0.01% | 3816 |
|
|
2019
Q4 | $156K | Buy |
+16,385
| New | +$156K | ﹤0.01% | 3794 |
|